APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Solid Dosage Pharmaceutical Formulation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Solid Dosage Pharmaceutical Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchOral Solid Dosage Pharmaceutical Formulation Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Solid Dosage Pharmaceutical Formulation Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Oral Solid Dosage Pharmaceutical Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Solid Dosage Pharmaceutical Formulation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Solid Dosage Pharmaceutical Formulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Solid Dosage Pharmaceutical Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Solid Dosage Pharmaceutical Formulation include Novartis, Merck, Eli Lilly, Pfizer, AbbVie, AstraZeneca, Gilead, Bristol-Myers Squibb and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Oral Solid Dosage Pharmaceutical Formulation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Solid Dosage Pharmaceutical Formulation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Solid Dosage Pharmaceutical Formulation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oral Solid Dosage Pharmaceutical Formulation market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Solid Dosage Pharmaceutical Formulation Segment by Company

Novartis

Merck

Eli Lilly

Pfizer

AbbVie

AstraZeneca

Gilead

Bristol-Myers Squibb

Boehringer Ingelheim

Oral Solid Dosage Pharmaceutical Formulation Segment by Type

Immediate Release

Extended Release

Others

Oral Solid Dosage Pharmaceutical Formulation Segment by Application

Hospital Pharmacy

Drug Stores

Retail Pharmacy

Others

Oral Solid Dosage Pharmaceutical Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Solid Dosage Pharmaceutical Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Solid Dosage Pharmaceutical Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Solid Dosage Pharmaceutical Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oral Solid Dosage Pharmaceutical Formulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Solid Dosage Pharmaceutical Formulation industry.

Chapter 3: Detailed analysis of Oral Solid Dosage Pharmaceutical Formulation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Solid Dosage Pharmaceutical Formulationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Immediate Release Table 3. Key Players of Extended Release Table 4. Key Players of Others Table 4. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacy Table 6. Key Players of Drug Stores Table 7. Key Players of Retail Pharmacy Table 8. Key Players of Others Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2021-2026) Table 12. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2027-2032) Table 14. Oral Solid Dosage Pharmaceutical Formulation Industry Trends Table 15. Oral Solid Dosage Pharmaceutical Formulation Industry Drivers Table 16. Oral Solid Dosage Pharmaceutical Formulation Industry Opportunities and Challenges Table 17. Oral Solid Dosage Pharmaceutical Formulation Industry Restraints Table 18. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Company (2021-2026) Table 20. Global Oral Solid Dosage Pharmaceutical Formulation Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Oral Solid Dosage Pharmaceutical Formulation Key Company Head Office and Area Served Table 22. Global Oral Solid Dosage Pharmaceutical Formulation Company, Product Type & Application Table 23. Global Oral Solid Dosage Pharmaceutical Formulation Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Oral Solid Dosage Pharmaceutical Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2021-2026) Table 30. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2027-2032) Table 31. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2021-2026) Table 35. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 40. Novartis Recent Development Table 41. Merck Company Information Table 42. Merck Business Overview Table 43. Merck Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Merck Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 45. Merck Recent Development Table 46. Eli Lilly Company Information Table 47. Eli Lilly Business Overview Table 48. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 50. Eli Lilly Recent Development Table 51. Pfizer Company Information Table 52. Pfizer Business Overview Table 53. Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 55. Pfizer Recent Development Table 56. AbbVie Company Information Table 57. AbbVie Business Overview Table 58. AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AbbVie Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 60. AbbVie Recent Development Table 61. AstraZeneca Company Information Table 62. AstraZeneca Business Overview Table 63. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 65. AstraZeneca Recent Development Table 66. Gilead Company Information Table 67. Gilead Business Overview Table 68. Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Gilead Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 70. Gilead Recent Development Table 71. Bristol-Myers Squibb Company Information Table 72. Bristol-Myers Squibb Business Overview Table 73. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 75. Bristol-Myers Squibb Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 82. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032) & (US$ Million) Table 83. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 84. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032) & (US$ Million) Table 85. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) Table 87. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032) Table 88. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) Table 94. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032) Table 95. China Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 96. China Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032) & (US$ Million) Table 97. China Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 98. China Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) Table 105. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Oral Solid Dosage Pharmaceutical Formulation Product Image Figure 2. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Type: 2025 VS 2032 Figure 4. Immediate Release Image Figure 5. Extended Release Image Figure 6. Others Image Figure 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2025 VS 2032 Figure 9. Hospital Pharmacy Image Figure 10. Drug Stores Image Figure 11. Retail Pharmacy Image Figure 12. Others Image Figure 13. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 15. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Oral Solid Dosage Pharmaceutical Formulation Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2021-2032) Figure 22. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2021-2032) Figure 24. North America Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 25. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032) Figure 26. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032) Figure 27. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 28. United States Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 29. Canada Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 31. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 32. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032) Figure 33. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032) Figure 34. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 35. Germany Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 36. France Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 38. Italy Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 39. Russia Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 41. China Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 42. China Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032) Figure 43. China Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032) Figure 44. Asia Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 45. Asia Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032) Figure 46. Asia Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032) Figure 47. Asia Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 48. Japan Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 52. India Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 53. Australia Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032) Figure 58. Brazil Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 63. UAE Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 65. Chile Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate Release
  • Extended Release
  • Others
Applications
  • Hospital Pharmacy
  • Drug Stores
  • Retail Pharmacy
  • Others
Companies covered
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • AbbVie
  • AstraZeneca
  • Gilead
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Immediate Release
  5. 1.2.3 Extended Release
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacy
  10. 1.3.3 Drug Stores
  11. 1.3.4 Retail Pharmacy
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Oral Solid Dosage Pharmaceutical Formulation Growth Trends by Region
  15. 1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2021-2026)
  17. 1.5.3 Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Oral Solid Dosage Pharmaceutical Formulation Market Dynamics
  1. 2.1 Oral Solid Dosage Pharmaceutical Formulation Industry Trends
  2. 2.2 Oral Solid Dosage Pharmaceutical Formulation Industry Drivers
  3. 2.3 Oral Solid Dosage Pharmaceutical Formulation Industry Opportunities and Challenges
  4. 2.4 Oral Solid Dosage Pharmaceutical Formulation Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Company (2021-2026)
  2. 3.2 Global Oral Solid Dosage Pharmaceutical Formulation Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oral Solid Dosage Pharmaceutical Formulation Key Company Head office and Area Served
  4. 3.4 Global Oral Solid Dosage Pharmaceutical Formulation Company, Product Type & Application
  5. 3.5 Global Oral Solid Dosage Pharmaceutical Formulation Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oral Solid Dosage Pharmaceutical Formulation Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oral Solid Dosage Pharmaceutical Formulation Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oral Solid Dosage Pharmaceutical Formulation Tier 1, Tier 2, and Tier 3
4 Oral Solid Dosage Pharmaceutical Formulation Market by Type
  1. 4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2032)
  3. 4.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Type (2021-2032)
5 Oral Solid Dosage Pharmaceutical Formulation Market by Application
  1. 5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2032)
  3. 5.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AbbVie Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Gilead
  38. 6.7.1 Gilead Company Information
  39. 6.7.2 Gilead Business Overview
  40. 6.7.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Gilead Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  42. 6.7.5 Gilead Recent Developments
  43. 6.8 Bristol-Myers Squibb
  44. 6.8.1 Bristol-Myers Squibb Company Information
  45. 6.8.2 Bristol-Myers Squibb Business Overview
  46. 6.8.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032)
  2. 7.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
  3. 7.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026)
  4. 7.2.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032)
  5. 7.2.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032)
  6. 7.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
  7. 7.3.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026)
  8. 7.3.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032)
  9. 7.3.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032)
  10. 7.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
  11. 7.4.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  13. 7.4.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032)
  14. 7.4.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032)
  2. 8.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
  3. 8.2.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032)
  6. 8.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
  7. 8.3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032)
  10. 8.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
  11. 8.4.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032)
  2. 9.2 China Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
  3. 9.2.1 China Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026)
  4. 9.2.2 China Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032)
  5. 9.2.3 China Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032)
  6. 9.3 China Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
  7. 9.3.1 China Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026)
  8. 9.3.2 China Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032)
  9. 9.3.3 China Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032)
  2. 10.2 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
  3. 10.2.1 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032)
  6. 10.3 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
  7. 10.3.1 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032)
  10. 10.4 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
  11. 10.4.1 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst